21 CFR 170.260
§ 170.260 Steps you may take before FDA responds to your GRAS notice.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 170.260, § 170.260 Steps you may take before FDA responds to your GRAS notice, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/84909
- Permanent ID
ys:prov:84909@1- SHA-256
302fe62e53d25986d3881a3d47bdd7fd79d05121b15b573bdffca91b465aecea
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) You may submit a timely amendment to your filed GRAS notice, to update your GRAS notice or in response to a question from us, before we respond to your notice by letter in accordance with § 170.265(b)(1) or cease to evaluate your notice in accordance with § 170.265(b)(3).
(b) At any time before we respond to your GRAS notice in accordance with § 170.265(b)(1), you may request in writing that we cease to evaluate your GRAS notice. Your request does not preclude you from submitting a future GRAS notice in accordance with this subpart with respect to the notified substance.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.